Banner
Home

Did Aaron Hernandez Have CTE? Print E-mail
Written by FHI's Week in Review   
Monday, 24 April 2017 17:16

Michael McCann, in an April 20 SI.com post, reports that Aaron Hernandez's brain has been donated to Boston University's CTE research project. Once a star tight end for the New England Patriots, Hernandez was serving a life sentence for murder. He committed suicide in his prison cell earlier this month.

Read more in the current issue of Week in Review>>

Last Updated on Monday, 24 April 2017 17:20
 
Lawmakers Seek to Expand Medicare Coverage of Telemedicine Again Print E-mail
Written by Vitale Health Law   
Tuesday, 18 April 2017 17:20

Congress is taking another crack at expanding Medicare coverage for services delivered via telemedicine. U.S. Senators Cory Gardner (R-CO) and Gary Peters (D-MI) recently introduced bipartisan legislation that would require the Center for Medicare and Medicaid Innovation (CMMI) to "test the effect of including telehealth services in Medicare health care delivery reform models." CMMI's role is to support the development and testing of innovative health care payment and service delivery models.

Dubbed, the Telehealth Innovation and Improvement Act, the bill is designed to expand access to healthcare for rural patients who lack access to healthcare. Currently, Medicare covers limited telehealth services, "setting a poor industry standard, discouraging innovation, and restricting access to specialized services," according to a news release issued by Gardner's office.

In addition to testing, the bill would direct CMMI to have an independent evaluation conducted to assess the telehealth models for cost, effectiveness, and improvement in quality of care without increasing the cost of delivery. If the telehealth model meets these criteria, then the model would be covered through the Medicare program.

Read More

Last Updated on Tuesday, 18 April 2017 17:30
 
23andMe Receives FDA Nod Print E-mail
Written by FHI's Week in Review   
Monday, 10 April 2017 16:49

According to an FDA.gov news release dated 4.6.17:
The U.S. Food and Drug Administration (FDA) today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual's genetic predisposition to certain medical diseases or conditions, which may help to make decisions about lifestyle choices or to inform discussions with a health care professional.                                 

Read more in the current issue of Week in Review>> http://conta.cc/2nVaaSF 

Last Updated on Tuesday, 18 April 2017 17:33
 
Sponsor Showcase Print E-mail
Written by Sponsor   
Friday, 14 April 2017 00:00
 
bdo-ftl-florida-health-industry-ad-9-16 final
Last Updated on Friday, 14 April 2017 17:28
 


Banner
Website design, development, and hosting provided by
Netphiles